caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1700883899

Michele BaltusMD

PRACTICEHUNTINGTON DRUGSSee all providers at this practice →
Family PracticeHuntington Station, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,509
Unique beneficiaries
—
Total services
2,242
Distinct HCPCS
13
Medicare payment
$160K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 3,705 Family Practice providers in NY — top quintile (cohort median 473).
REFERRAL NETWORK

Where Michele Baltus's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 8 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Northwell Health Laboratories
Clinical Laboratory · New Hyde Park, NY
132414
Mark Wax
Diagnostic Radiology · Huntington Station, NY
96232
Evan Held
Ophthalmology · Huntington Station, NY
2050
Jay Steinberg
Gastroenterology · Huntington Station, NY
1839
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Melville, NY
1577
David Gabbaizadeh
Gastroenterology · Huntington Station, NY
1527
Faisal Siddiqui
General Surgery · Huntington Station, NY
1460
Tamara Mohuchy
Diagnostic Radiology · Bedford Hills, NY
1441
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
963
Beneficiaries
—
Total drug cost
$90K
Distinct drugs
29
Brand share
19.0%
Top prescribed drugs
Atorvastatin Calcium94 claims
Azelastine Hcl90 claims
Levothyroxine Sodium87 claims
Meloxicam71 claims
Rosuvastatin Calcium60 claims
QUALITY · MIPS · 2024
Final MIPS score
90.8
Quality
91.8
Cost
75.2
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.66%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$86
Payment records
4
By payment type
Food and Beverage$86